Hyundai Venture Investment Corporation

Hyundai Venture Investment Corporation is a venture capital firm established in 1997 and headquartered in Seoul, South Korea. The firm focuses on supporting new entrepreneurs and venture companies by providing essential resources and expertise. It seeks to invest in various sectors, including consumer products, information technology, healthcare, manufacturing, life sciences, e-commerce, and advertising technology, primarily in Asia. Hyundai Venture Investment Corporation aims to partner with companies that possess innovative technologies but may lack stable financial and management structures. The firm offers a wide range of support services to its portfolio companies, such as management control, technology consulting, and financial assistance, facilitating their growth and development in competitive markets.

Joo-Yol Choi

Vice President

Sang Wook Han

Senior Vice President

Yong Duck Seo

Executive Vice President

25 past transactions

Polaris3D

Series B in 2024
Polaris3d offers indoor autonomous navigating solution.

Headless

Seed Round in 2022
Headless is a technology company that specializes in creating a direct-to-consumer platform for commerce businesses. It offers a software-as-a-service (SaaS) solution that utilizes artificial intelligence to enhance marketing and shopping channels. By developing data pipelines, Headless enables companies to efficiently gather and utilize product and customer information, facilitating flexible interactions across various frontends. The company's innovative approach allows for the separation of the frontend, which engages consumers, from the backend, which delivers essential functionality, much like assembling Lego bricks. This structure supports automatic advertisement bidding, empowering firms to optimize their advertising strategies and enhance their overall commerce operations.

Amicogen

Post in 2022
Amicogen is an industrial biotechnology company based in Korea, specializing in the development, production, and distribution of bioproducts and health functional food ingredients. The company's diverse product portfolio includes special enzymes, N-acetylglucosamine, pinitol, D-Chiro-inositol, collagen peptides, and protein A chromatography resins. Additionally, Amicogen offers products such as endo-lac, ginseng extraction powder, cauliflower mushrooms, chitosan oligosaccharides, chitoslim, and keyclean, catering to the growing demand for innovative solutions in the health and wellness sectors.

Anterogen

Post in 2022
Anterogen is a bio-venture company focused on the research and development of cell therapy products and orphan drugs utilizing adult stem cells. The company has developed several products, including Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. In addition to its product offerings, Anterogen provides cell banking services and analytical services, which encompass sample analysis for clinical studies. Through its innovative approach, Anterogen aims to advance therapeutic options in the field of regenerative medicine.

Apitbio

Series A in 2021
APITBIO is a biotechnology company focused on the research and development of antibody therapeutics, particularly in the field of anti-cancer drugs. The company utilizes a comprehensive platform that encompasses various stages of drug development, including screening, discovery, optimization, and production of monoclonal and double antibodies. By advancing its research in antibody therapeutics, APITBIO aims to address significant unmet medical needs within the oncology sector, providing hospitals with innovative treatment options for cancer patients.

Irang Tech

Seed Round in 2020
Irang Tech develops, manufactures, and supplies communication components.

CeREELs

Series A in 2020
We are a series B startup that was founded in October 2019 with $11.7 million in total funding. Unlike conventional creative studios, we work with various independent musicians, artists, and studios around the world to create a much more varied and inclusive content that we hope will resonate with the younger generations. We hope to make our viewers smile and join them in meaningful conversations for years to come. https://www.youtube.com/c/CeREELs/

Autocrypt

Series A in 2020
AUTOCRYPT is a leader in mobility security technologies, specializing in end-to-end vehicle security for autonomous vehicles and their surrounding infrastructure. The company employs a multi-layered approach to enhance transportation security, focusing on various solutions including V2X/C-V2X communications, V2G systems with Plug & Charge security, in-vehicle security, and fleet management. Recognized for its innovative contributions, AUTOCRYPT was awarded the Best Auto Cybersecurity Product/Solution in 2019 and was a finalist for Automotive Tech Company of the Year in 2020. By ensuring the security of all vehicle connections, AUTOCRYPT enables automakers to prioritize safety before vehicles are deployed on the road.

EnergyX

Series A in 2020
Energy X Inc. is an AI-driven platform based in Seoul, South Korea, focused on the solar energy sector and the broader renewable energy market. Established in 2019, the company connects various energy market participants, including households, engineering firms, and investors, through its online and mobile Social Energy Platform. Energy X facilitates the development of renewable energy projects, encompassing photovoltaic power generation, hydrogen fuel cells, and biodiesel. Additionally, it provides services related to licensing, design, construction, financing, and management of energy projects. The platform aims to simplify the sourcing of energy from natural resources and aims to establish itself as a global standard for clean energy development and energy securitization.

Neosapience

Series A in 2020
Neosapience, Inc. is a South Korean company specializing in artificial intelligence-driven voice synthesis and avatar technologies. Founded in 2017 and headquartered in Seoul, the company has developed innovative products like Icepeak.AI and Typecast, which allow users to generate speech that closely mimics individual voice characteristics, including prosody and emotion. Icepeak.AI is an online platform that learns and replicates voice features, while Typecast, launched in 2019, has gained popularity as an AI-powered content creation service, used by over 2 million users across 225 countries. Additionally, Neosapience offers a mobile application, ICEPEAK, enabling users to create personalized voice interactions. The company aims to redefine content creation through advanced AI technologies, making voice-over processes more accessible and efficient.

Funda

Series B in 2020
Funda is a P2P finance service that connects multiple investors to sound stores that need funds and creates a financial service.

RecensMedical

Series B in 2019
Recens Medical is a developer of precision cooling technology designed for medical applications. The company's innovative device can rapidly and accurately cool the surface of the eye, facilitating novel therapies and expanding treatment alternatives. This technology offers precise temperature control, allowing for rapid anesthesia of ocular surfaces and providing therapeutic effects for various dermatologic and orthopedic conditions. By minimizing tissue damage, Recens Medical aims to enhance patient experiences, making medical procedures more painless and efficient.

Swit

Seed Round in 2019
Swit Technologies, Inc., established in 2017 and headquartered in San Francisco, California, specializes in developing team collaboration software. Its application integrates advanced team communication with high-performance task management, streamlining business processes and enhancing team productivity by consolidating multiple apps into a single platform.

Piolink

Funding Round in 2014
Piolink is a company that specializes in network equipment and solutions, focusing on the development and sales of advanced networking technologies. It operates in the field of application networking, offering a range of products such as application delivery controllers, web application firewalls, and network switches. In addition to its hardware offerings, Piolink provides various services, including managed security services, security consulting, and tailored security solutions. The company's expertise positions it as a key player in enhancing network performance and security for its clients.

Techcross

Venture Round in 2014
Techcross is a manufacturer of ballast water management systems focused on protecting the marine environment. The company develops innovative systems that employ electrolysis technologies to prevent the pollution of ship ballast water from large vessels, including tankers and container ships. By enabling the treatment of invasive marine species contained in ballast water, Techcross plays a crucial role in promoting sustainable maritime practices across various countries.

Anygen

Venture Round in 2014
Anygen Co., Ltd., established in 2000, is a South Korean bio-venture company specializing in the manufacture of peptide Active Pharmaceutical Ingredients (APIs) and drug development. The company produces a range of peptides, including GMP, generic, custom, and catalog varieties, and offers related services. Anygen is also engaged in the development of novel drugs, such as AGM-130 for breast cancer, AGM-212 for type 2 diabetes, AGM-251 for neuropathic pain, and AGM-290 for MRSA infection treatment. Headquartered in Gwangju, Anygen is the first bio-venture company in the Gwangju and Jeonnam province, and it aims to expand globally. The company supplies high-quality peptide medicinal materials, approved by GMP, at competitive prices, contributing to the stability of the peptide drug raw materials market and promoting public health.

Lumantek

Venture Round in 2010
Lumantek designs and develops electronic test and measurement instruments, broadcast transmission and digital media convergence systems.

DRTECH

Venture Round in 2006
DRTECH Corporation is a South Korean company that specializes in the development, manufacture, and sale of flat-panel X-ray detectors for digital radiography. Founded in 2000 and headquartered in Seongnam, DRTECH offers a range of products, including indirect and direct flat-type panel detectors, as well as solutions for digital mammography. Its notable products include Exprimer, FLAATZ, RoseM, Expeed, and Extream, which serve various imaging needs in the medical field both in South Korea and internationally.

TAEJIN Technology

Venture Round in 2004
TAEJIN Technology Co. Ltd. is a South Korean company specialized in the design and manufacture of power management integrated circuits (ICs). Established in 2000 and headquartered in Daejeon, TAEJIN Technology offers a diverse range of products including voltage stabilizers, LDO voltage regulators, step-down switching voltage regulators, and various signal conditioning products. The company also provides DDR termination, USB switches, LED drivers, and converters, serving sectors such as computing, consumer electronics, communication, and automotive applications. Their products are marketed under the HTC Korea brand name, showcasing the company's commitment to quality and innovation in the power management sector, both domestically and internationally.

Genomine

Venture Round in 2003
GenoMine, Inc. is a biotechnology company founded in 1999 and based in Pohang, South Korea. The company specializes in the research and development of genetic products, focusing on the discovery of functional genes and disease markers. Its expertise lies in advanced techniques such as functional dielectric and proteome analysis, which facilitate the identification of novel genes. GenoMine aims to create high added value through technology transfer and the application of its discoveries across various sectors, particularly in agriculture. By identifying plant genes related to yield enhancement and environmental stress resistance, the company supports researchers and agricultural stakeholders in improving crop production and protection strategies through innovative gene utilization technologies.

Enuri

Venture Round in 2003
Enuri is a price comparison company based in South Korea.

Genexine

Venture Round in 2003
Genexine, Inc. is a clinical stage biotechnology company based in Seongnam, South Korea, specializing in the development and commercialization of immunotherapeutics and long-acting biologics. The company utilizes its proprietary hyFc platform to create differentiated agonistic protein therapeutics and has developed the Immune Enhancing Technology, a therapeutic DNA vaccine platform. Genexine's product pipeline includes several candidates currently in clinical trials: GX-H9 for adult and pediatric growth hormone deficiency, GX-E2 for induced anemia, GX-G3 for neutropenia, and GX-G6 for diabetes. Additionally, GX-188E is being studied in combination with KEYTRUDA for cervical cancer treatment. Genexine has also partnered with Binex Co. Ltd. to co-develop a COVID-19 vaccine. Founded in 1999, Genexine, Inc. aims to deliver innovative medicines that significantly improve patient outcomes.

Okins Electronics

Venture Round in 2002
Okins Electronics Co., Ltd. is a South Korean company specializing in the manufacture and sale of semiconductor inspection sockets and interconnection solutions for electrical testing of integrated circuit devices. Founded in 1998 and headquartered in Uiwang-si, the company offers a diverse range of products, including burn-in sockets, test sockets, memory module test sockets, and SSD module sockets. It also provides semiconductor test services such as test development, wafer probing, and package testing for various applications, including analog, mixed signal, LED, MEMS, and sensor devices. In addition to its core offerings, Okins Electronics develops and produces MEMS pins using a semiconductor batch exposure process and integrates electronic and mechanical components. The company serves a global clientele across multiple countries, including China, South Korea, the United States, Thailand, Singapore, Taiwan, the Philippines, and Japan.

Mediforum Pharm

Venture Round in 2002
Mediforum Pharm is a pharmaceutical company.

Hyundai Domestic Courier Service

Venture Round in 2001
HYUNDAI GLOVIS Co., Ltd is a Korea-based company mainly engaged in the logistics business. Along with subsidiaries, the Company operates its business through three segments. The Logistics segment is involved of the development and provision of the domestic and overseas logistics network to provide customized information technology (IT) systems, as well as the provision of real-time logistics information services that are applied throughout the logistics process. The Complete Knocked Down (CKD) segment is involved of the provision of integrated management services for everything from ordering / collection of auto parts to packing, marine / air transportation till factory payment. In addition, the Company is involved of used car auction business. The Other segment is engaged in the trading business of aluminums and copper steels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.